2 Minutes with Joey - LLY Stock News

2 Minutes with Joey - LLY Stock News

2 Minutes with Joey
Country USA
Language EN
Episodes 2
Latest 13.08.2026

A quick daily recap of Eli Lilly (LLY) stock performance, explaining what the stock did and why in plain English. The podcast is for information and entertainment only, not financial advice.

Episodes

  • LLY Today - Aug 13: Lawsuits Weigh on Stock
    LLY Today - Aug 13: Lawsuits Weigh on Stock 13.08.2026 1m
    Hey there! It’s Joey here, your go-to guy for stock talk. I’ve been in the investing game for a while, and today, we’re looking at Eli Lilly, or LLY for short. Today was a bit of a rough one for them—stock dipped just a tiny bit, down 0.03%. Not a huge drop, but still a red day.So, what’s the deal? Eli Lilly had some news that didn’t sit well with investors. They’ve got ongoing lawsuits related to their obesity drug, Retatrutide, which is causing some worries for folks who are keeping an eye on the stock. People hit the sell button pretty quickly when they heard about it. You know how it goes—...
  • LLY Today - Aug 12: Weight Loss Pill Approval
    LLY Today - Aug 12: Weight Loss Pill Approval 12.08.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down today’s market action. We’re talking about Eli Lilly, and today was a red day for them, down just about 0.81%. So, what went down? The stock slipped a bit, and it wasn’t a huge surprise. It seems like investors were feeling a little jittery today. There were some mixed signals in the market, and Eli Lilly didn’t exactly stand out among its peers. It’s like they were just kind of there while others were making moves. Now, why’d this happen? Well, part of the chatter was about their weight loss pill snagging its first...
  • LLY Today - Aug 11: Earnings Anticipation
    LLY Today - Aug 11: Earnings Anticipation 11.08.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor. Just hanging out, breaking down the day for you. Today we're talking about Eli Lilly, and it was a bit of a red day for them. The stock dipped about 1%—not huge, but still a bummer.So, what went down? Well, LLY started the day with some solid energy, but as the hours rolled on, it got a bit of a slow bleed. People were probably feeling the jitters ahead of earnings coming up soon. You know how that goes—everyone gets a little anxious when big numbers are about to drop.Now, let’s chat about the why. Analysts have been buzzing about...
  • LLY Today - Aug 10: Earnings Buzz and Upgrades
    LLY Today - Aug 10: Earnings Buzz and Upgrades 10.08.2026 1m
    Hey there! It's Joey, your friendly investor buddy, here to break down the day for Eli Lilly, or LLY for short. Today was a green day for them, up about 2.14%. Not too shabby!So, what went down? LLY saw a nice little bump in its stock price today. You know how it goes, a lot of chatter around earnings coming up, and people are getting excited. That anticipation can really get the momentum going.Now, let’s talk about why this happened. There’s a lot of buzz surrounding Eli Lilly right now. A few articles are floating around, suggesting that the stock is kind of in a sweet spot. Some folks are s...
  • LLY Today - Aug 09: Mixed Signals for Eli Lilly
    LLY Today - Aug 09: Mixed Signals for Eli Lilly 09.08.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor. Let’s break down what went down with Eli Lilly today. Spoiler alert: it was a red day for LLY. It slipped about half a percent. So, here's the scoop: the stock got hit with a little bit of selling pressure today. It opened up, looked promising for a hot minute, but then it kinda fizzled out. We saw some action, but it didn’t really pop like everyone hoped. Now, why the dip? Well, a lot of chatter around the GLP-1 market is stirring things up. There’s buzz about how Eli Lilly stacks up against competitors like Viking Therapeutics....
  • LLY Today - Aug 08: Slight Dip Amidst Mixed News
    LLY Today - Aug 08: Slight Dip Amidst Mixed News 08.08.2026 1m
    Hey there! It’s Joey, your friendly investor here. I’ve been in the game for a while, and today we’re talking about Eli Lilly, or LLY for short. It was a bit of a red day, down just a smidge, like half a percent. Not a huge drop, but still, it got a little smoked.So, what went down? The stock dipped about six bucks, closing around 1185. Not exactly a wild ride, but you know how it goes. Sometimes stocks just sort of chill, and today was one of those days for Lilly. Now, why did this happen? Well, there’s a mix of stuff going on. First off, Truist decided to raise their price target for Lilly,...
  • LLY Today - Aug 07: Eli Lilly's GLP-1 Sales Boost
    LLY Today - Aug 07: Eli Lilly's GLP-1 Sales Boost 07.08.2026 1m
    Hey there! It’s Joey, your friendly neighborhood investor. I’ve been around the block a few times, and today I’m breaking down Eli Lilly, or LLY, for August 7th. Spoiler alert: it was a green day, just barely, up 0.05%. So, what went down? Honestly, not a ton of movement. The stock barely budged, but it’s still hanging in there. Volume was steady, which is kind of a good sign that folks are still interested, even if the price didn’t jump through the roof.Now, here’s the juicy part on why it moved a bit. Eli Lilly is riding high on the success of their GLP-1 drugs, which are doing really well....
  • LLY Today - Aug 06: GLP-1 Sales Boost
    LLY Today - Aug 06: GLP-1 Sales Boost 06.08.2026 1m
    Hey there! It’s Joey, your friendly neighborhood investor. I’ve been doing this for a while, and today I’m breaking down Eli Lilly, ticker LLY. Spoiler alert: it was a green day, up about 1.7%.So, here’s the scoop. LLY climbed today, and it wasn’t just a small bump. The stock got a nice lift, thanks to some solid news about their GLP-1 drugs. These are the ones that help with weight loss and diabetes, and they’re really starting to take off. Analysts are buzzing about how these sales are widening Lilly's lead over competitors, especially Novo. That’s a big deal, right? Now, why did this happen...
  • LLY Today - Aug 05: Strong Demand for Weight Loss Drugs
    LLY Today - Aug 05: Strong Demand for Weight Loss Drugs 05.08.2026 1m
    Hey, what's up? It's Joey here, your friendly investor who's been in the game for a while. So, let’s talk about Eli Lilly today. It was definitely a green day for LLY, up about 4.8%. Not too shabby!So, what happened? Lilly's stock got a nice boost, and honestly, it’s all about those GLP-1 drugs. You know, those weight loss meds everyone’s been buzzing about? They totally crushed sales expectations. Like, blew them out of the water. People are really loving these drugs, and that’s translating into some serious cash for Lilly. Now, why did it jump like this? Well, the company reported some stron...
  • LLY Today - Aug 04: Stock Split Buzz Heating Up
    LLY Today - Aug 04: Stock Split Buzz Heating Up 04.08.2026 1m
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down what happened with Eli Lilly today. So, LLY had a pretty chill day, barely moving, just up a smidge at 0.28%. Not exactly a wild ride, but hey, it’s something!Now, let’s talk about why. There’s been a lot of chatter around Eli Lilly lately, especially with their obesity drug making some waves. Folks are starting to wonder if a stock split could be on the horizon. Yeah, that one stung when I heard it, because a split usually gets people hyped! It's like a way to make shares more accessible and can potentially drive mo...
  • LLY Today - Aug 03: FDA Breakthrough for Cancer Therapy
    LLY Today - Aug 03: FDA Breakthrough for Cancer Therapy 03.08.2026 1m
    Hey there! It’s Joey here, your friendly investor buddy. I’ve been in the game for a while, and today I’m breaking down Eli Lilly, ticker LLY. Spoiler alert: it was a red day for them, down about 2.3%. So, what happened? Well, LLY took a hit today. It got smoked, dropping over 26 bucks. That’s gotta sting, right? But before we get too bummed out, let’s chat about why this happened.Now, here’s the scoop. There was some exciting news earlier in the day. Eli Lilly’s got a second FDA breakthrough designation for their cancer therapy, Olomorasib. That’s a big deal! It means they’re on the fast trac...
  • LLY Today - Aug 02: Slight dip amid market noise
    LLY Today - Aug 02: Slight dip amid market noise 02.08.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor. Today, I'm breaking down what's up with Eli Lilly, and spoiler alert: it was a red day. The stock dipped about half a percent. Not a massive drop, but still, nobody likes seeing red, right?So, here’s what went down. LLY started the day with a bit of energy but faced some selling pressure, which took it down a notch by the close. It kinda felt like a slow bleed, you know? Not the dramatic moves we sometimes see, but still a bummer if you’re holding onto shares.Now, why did it happen? Well, the chatter around the market was pretty m...
  • LLY Today - Aug 01: Earnings Looming
    LLY Today - Aug 01: Earnings Looming 01.08.2026 1m
    Hey there! It’s Joey, your go-to guy for stock chat, and I've been in the investing game for a while. Today, we’re talking about Eli Lilly, and it was a red day for them, down just a smidge at about half a percent. So, what went down? Eli Lilly’s stock got smoked today, losing a little over six bucks. The volume was pretty average, so nothing too wild there. It seems like investors were feeling a bit cautious. Now, why the dip? Well, a couple of things are swirling around. Earnings reports are coming up soon, and people are getting a little jittery. You know how it goes—when earnings are on th...
  • LLY Today - Jul 31: Eli Lilly Takes a Dip
    LLY Today - Jul 31: Eli Lilly Takes a Dip 31.07.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today, we’re chatting about Eli Lilly, ticker LLY. So, it was a bit of a rough day for them, down about 2.8%. Yeah, that one stung a bit.So, what went down? Well, LLY opened up and seemed like it might hang in there, but then it just kinda faded. The stock got smoked as the day went on. Volume was right around the average, so nothing crazy there. Just a slow bleed into the red.Now, why did this happen? It looks like investor vibes were mixed. There’s been chatter about Eli Lilly investing a h...
  • LLY Today - Jul 30: Earnings Report Looms
    LLY Today - Jul 30: Earnings Report Looms 30.07.2026 1m
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Eli Lilly today. So, LLY had a rough day, dropping about 3.8%. Yeah, that one stung.The stock was kind of on a slow bleed through the day. People were hitting that sell button, and it didn’t help that everyone’s eyes are glued to the upcoming earnings report. You know how it goes—everyone gets a bit jittery before earnings, and LLY felt that pressure. Now, why the drop? Well, a couple of articles floating around had some folks worried. One piece from Morningstar was questioning whether LLY is a bu...
  • LLY Today - Jul 29: Earnings Buzz Looms
    LLY Today - Jul 29: Earnings Buzz Looms 29.07.2026 1m
    Hey there! It’s Joey, your friendly longtime investor here, breaking down the day in Eli Lilly. So, LLY had a bit of a down day, slipping just a smidge—like, less than a tenth of a percent. Not a huge deal, but still, it got a little red.So, what went down? Well, the stock barely moved, which can feel kinda boring. But it’s all about what’s coming up. Investors are getting antsy with the earnings report just around the corner on August 5. That’s got people buzzing. You know how it is—everyone’s trying to guess if the numbers will be good or bad. It’s like waiting for a grade on a test you didn...
  • LLY Today - Jul 28: Analysts Lift Targets
    LLY Today - Jul 28: Analysts Lift Targets 28.07.2026 1m
    Hey there! It’s Joey here, your friendly neighborhood investor. Let’s talk about Eli Lilly, or LLY for short. Today was a green day for them, up about 2.2%. Not too shabby!So here’s the scoop. LLY started strong and kept that momentum rolling. People are pretty pumped about their prospects, especially after some analysts decided to boost their price targets. They’re looking at Lilly's GLP-1 drugs and thinking, “Yeah, this is gonna be big.” It’s like when your favorite band drops a new album and you just know it’s gonna be a hit.But it’s not all sunshine and rainbows. Goldman Sachs threw some s...
  • LLY Today - Jul 27: Eli Lilly's Mixed Day
    LLY Today - Jul 27: Eli Lilly's Mixed Day 27.07.2026 1m
    Hey there! It’s Joey here, your friendly investor buddy, breaking down the day for you. Today, we’re talking about Eli Lilly, and it was a bit of a mixed bag. The stock was up just a smidge, like 0.6% or so. Not exactly a wild ride, but hey, better than being in the red, right?So, what went down today? Well, Eli Lilly had a pretty interesting day in the headlines. They made waves by snagging a psychedelic drug developer for a whopping $3.8 billion. Yeah, you heard that right! That’s a big deal, and it’s got people buzzing about what Eli Lilly is planning next. But amidst all that excitement, t...
  • LLY Today - Jul 26: Buyout Buzz and Drug Approval
    LLY Today - Jul 26: Buyout Buzz and Drug Approval 26.07.2026 1m
    Hey there! It’s Joey, your friendly longtime investor here to break down the day. Today, we’re talking about Eli Lilly. It was a green day for LLY, up just under 1%. So, what went down? The stock was buzzing a bit, thanks to some big news. Eli Lilly just announced they’re buying out another company for a whopping $2.8 billion. That’s a serious chunk of change! And that’s not all – they’re also gearing up to submit their obesity drug for approval after some solid late-stage trial results. Yeah, that one stung for the competition. Now, why all the excitement? Well, the buyout is getting people h...
  • LLY Today - Jul 25: Riding the Peptide Wave
    LLY Today - Jul 25: Riding the Peptide Wave 25.07.2026 1m
    Hey there! It’s Joey, your friendly investor buddy, here to break down what went down with Eli Lilly today. So, LLY had a pretty solid day, up about 0.86%. Not a wild ride, but hey, a win’s a win, right?So, here's the scoop. The stock didn’t move a ton, but it’s still cruising along. There’s been some buzz around Lilly's growth potential, especially with their new obesity treatments. These oral GLP-1 drugs are gaining traction, and people are really excited about it. Like, prescriptions are jumping up, and that’s always a good sign for a company.Now, why all the excitement? Well, a couple of a...

Popular in

The podcast also appears in the podcast charts of these countries.